Literature DB >> 11793013

A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis.

D L Eizirik1, T Mandrup-Poulsen.   

Abstract

Apoptosis is likely to be the main form of beta-cell death in immune-mediated diabetes mellitus in rodents and possibly in humans. Clarification of the regulation of beta-cell death could indicate novel sites for therapeutic intervention in Type I (insulin-dependent) diabetes mellitus. We review the molecular effectors and signal transduction of immune-mediated beta-cell apoptosis. Data obtained on non-obese diabetic (NOD) mice suggest that macrophages and CD4+ T-cells are the main cellular effectors, whereas CD8+ T-cells are more important initiators of the immune process leading to beta-cell death. Perforin could be the effector molecule utilized by CD8+ T-cell initiation, whereas CD4+ mediated beta-cell destruction is mostly dependent on Fas/FasL and the cytokines IFNgamma and TNF-alpha. The macrophage cytokine IL-1beta in combination with IFN-gamma and TNF-alpha, plays an important role for beta-cell dysfunction and death. Signal transduction by these cytokines involves: (i) binding to specific receptors, (ii) signal transduction by cytosolic kinases (especially the so-called mitogen- and stress-activated protein kinases) and/or phosphatases, (iii) mobilization of diverse transcription factors - with nuclear factor kappaB (NF-kappaB), AP-1 and STAT-1 probably playing key roles for beta-cell apoptosis; (iv) up-regulation or down-regulation of gene transcription. Recent data obtained by microarray and proteomic analysis suggest that the process of beta-cell apoptosis depends on the parallel and/or sequential up-regulation and down-regulation of considerable numbers of genes, which can be grouped in gene modules or patterns according to their functions. A detailed characterization of these "gene modules", and of the signalling pathways and transcription factors regulating them could allow us to understand the ultimate mechanisms leading to beta-cell apoptosis.

Entities:  

Mesh:

Year:  2001        PMID: 11793013     DOI: 10.1007/s001250100021

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  288 in total

1.  Genetic polymorphism of interleukin-1beta is associated with risk of type 1 diabetes mellitus in children.

Authors:  Dóra Krikovsky; Barna Vásárhelyi; András Treszl; Anna Körner; Attila Tordai; Tivadar Tulassay; László Madácsy
Journal:  Eur J Pediatr       Date:  2002-09       Impact factor: 3.183

2.  Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation.

Authors:  Jenny Barthson; Carla M Germano; Fabrice Moore; Adriano Maida; Daniel J Drucker; Piero Marchetti; Conny Gysemans; Chantal Mathieu; Gabriel Nuñez; Andrea Jurisicova; Decio L Eizirik; Esteban N Gurzov
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

Review 3.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

4.  Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells.

Authors:  K L A Souza; M Elsner; P C F Mathias; S Lenzen; M Tiedge
Journal:  Diabetologia       Date:  2004-07-10       Impact factor: 10.122

5.  STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammation.

Authors:  Fabrice Moore; Najib Naamane; Maikel L Colli; Thomas Bouckenooghe; Fernanda Ortis; Esteban N Gurzov; Mariana Igoillo-Esteve; Chantal Mathieu; Gianluca Bontempi; Thomas Thykjaer; Torben F Ørntoft; Decio L Eizirik
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

6.  Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro.

Authors:  I Stojanovic; T Saksida; I Nikolic; F Nicoletti; S Stosic-Grujicic
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

7.  Ciliary neurotrophic factor protects mice against streptozotocin-induced type 1 diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death.

Authors:  Luiz F Rezende; Gustavo J Santos; Everardo M Carneiro; Antonio C Boschero
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

8.  Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways.

Authors:  A E Karlsen; P E Heding; H Frobøse; S G Rønn; M Kruhøffer; T F Orntoft; M Darville; D L Eizirik; F Pociot; J Nerup; T Mandrup-Poulsen; N Billestrup
Journal:  Diabetologia       Date:  2004-12-02       Impact factor: 10.122

9.  α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.

Authors:  Peter A Gottlieb; Aimon K Alkanani; Aaron W Michels; Eli C Lewis; Leland Shapiro; Charles A Dinarello; Danny Zipris
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

Review 10.  Targeting the pancreatic β-cell to treat diabetes.

Authors:  Amedeo Vetere; Amit Choudhary; Sean M Burns; Bridget K Wagner
Journal:  Nat Rev Drug Discov       Date:  2014-02-14       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.